ASB3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.157900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.739250E-01
Normal-vs-Stage2
7.282200E-02
Normal-vs-Stage3
2.092400E-02
Normal-vs-Stage4
5.836600E-01
Stage1-vs-Stage2
8.597800E-01
Stage1-vs-Stage3
5.092100E-02
Stage1-vs-Stage4
3.859000E-01
Stage2-vs-Stage3
7.070200E-02
Stage2-vs-Stage4
2.478800E-01
Stage3-vs-Stage4
2.616000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.647800E-02
Normal-vs-AfricanAmerican
8.504500E-02
Normal-vs-Asian
1.294030E-01
Caucasian-vs-AfricanAmerican
6.778000E-01
Caucasian-vs-Asian
5.404800E-01
AfricanAmerican-vs-Asian
9.679800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.121600E-02
Normal-vs-Female
9.127700E-02
Male-vs-Female
6.494400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.883800E-02
Normal-vs-Age(41-60Yrs)
1.963800E-01
Normal-vs-Age(61-80Yrs)
3.773800E-02
Normal-vs-Age(81-100Yrs)
4.417900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.244190E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.866000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.135360E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.502440E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.589400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.661040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.351780E-02
Normal-vs-Daily Drinker
7.811900E-02
Normal-vs-Weekly Drinker
2.004200E-03
Normal-vs-Occasional Drinker
2.918400E-01
Normal-vs-Social Drinker
2.488300E-02
Non Drinker-vs-Daily Drinker
3.887600E-01
Non Drinker-vs-Weekly Drinker
1.296580E-01
Non Drinker-vs-Occasional Drinker
5.659000E-03
Non Drinker-vs-Social Drinker
5.048600E-01
Daily Drinker-vs-Weekly Drinker
4.822300E-02
Daily Drinker-vs-Occasional Drinker
9.098100E-02
Daily Drinker-vs-Social Drinker
8.554400E-01
Weekly Drinker-vs-Occasional Drinker
3.582900E-04
Weekly Drinker-vs-Social Drinker
3.184500E-02
Occasional Drinker-vs-Social Drinker
4.854200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.828100E-02
Normal-vs-Grade 2
9.983400E-03
Normal-vs-Grade 3
1.208490E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.563800E-02
Grade 1-vs-Grade 3
1.011210E-01
Grade 1-vs-Grade 4
5.828100E-02
Grade 2-vs-Grade 3
9.075600E-01
Grade 2-vs-Grade 4
9.983400E-03
Grade 3-vs-Grade 4
1.208490E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.526110E-02
Normal-vs-NonDiabetic
5.878200E-02
Diabetic-vs-NonDiabetic
2.857400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.868400E-02
Normal-vs-NoPancreatitis
3.825700E-02
Pancreatitis-vs-NoPancreatitis
9.743600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.660400E-02
Normal-vs-N1
6.872100E-02
N0-vs-N1
8.376000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.504800E-01
Normal-vs-TP53-NonMutant
6.814000E-02
TP53-Mutant-vs-TP53-NonMutant
3.359100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
